Company Filing History:
Years Active: 2022-2024
Title: Marco Matthies: Innovator in Synthetic Transfer RNA
Introduction
Marco Matthies is a prominent inventor based in Hamburg, Germany. He has made significant contributions to the field of genetic research, particularly in the development of synthetic transfer RNA. With a total of 2 patents, Matthies is recognized for his innovative approaches to addressing genetic diseases.
Latest Patents
One of Matthies' latest patents is focused on a synthetic transfer RNA with an extended anticodon loop. This invention provides a synthetic suppressor transfer RNA that is useful for the treatment of genetic diseases, such as cystic fibrosis, which are associated with nonsense mutations. The synthetic transfer RNA features an extended anticodon loop that includes two consecutive anticodon base triplets, designed to base-pair with two consecutive codon base triplets on an mRNA. Notably, one of these anticodon base triplets is configured to base-pair with a stop codon base triplet on the mRNA, enhancing the potential for therapeutic applications.
Career Highlights
Marco Matthies is currently employed at Arcturus Therapeutics, Inc., where he continues to advance his research in synthetic biology and genetic therapies. His work is pivotal in developing innovative solutions for complex genetic disorders.
Collaborations
Matthies collaborates with talented individuals in his field, including Zoya Ignatova and Andrew Torda. These partnerships foster a dynamic environment for innovation and research.
Conclusion
Marco Matthies stands out as a key figure in the realm of synthetic transfer RNA research. His inventions hold promise for the treatment of genetic diseases, showcasing the impact of innovative thinking in biotechnology.